Physician profile
Whitney Halgrimson
NPI 1861759805
$3,045.15
in general payments reported to CMS, 2019-2025
14 companies · $593 in 2025
The $593 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,686 · 2022: $85.97 · 2023: $540 · 2024: $141 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,815.28 | 2019-2025 | Rezum Generator, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $373.11 | 2023-2025 | Aquabeam Robotic System |
| Calyxo, INC. | $269.85 | 2025 | Cvac Aspiration System |
| Travere Therapeutics, INC. | $157.80 | 2019 | |
| Endo USA, INC. | $92.37 | 2024 | Xiaflex |
| Karl Storz Endoscopy-America | $86.75 | 2023 | Hopkins, Autocon |
| Endo Pharmaceuticals INC. | $71.80 | 2022-2023 | Xiaflex, Aveed, Edex |
| Laborie Medical Technologies Corp. | $48.36 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Abbvie INC. | $39.91 | 2022-2023 | |
| Myovant Sciences INC. | $21.29 | 2022 | |
| Urogen Pharma, INC. | $19.15 | 2024 | |
| Axonics, INC. | $17.96 | 2023 | Bulkamid |
| Amgen INC. | $16.80 | 2019 | |
| Medtronic, INC. | $14.72 | 2023 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Whitney Halgrimson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.